The push back on Sovaldi

Now watching

Next video starts in : 7 Play

The push back on Sovaldi

The push back on Sovaldi
Replay video
Up next

Big issue for us on the year is going to be earnings: Pro

Unlock your personal NFL Now stream by signing in to NFL.com

The push back on Sovaldi

by CNBC Videos 3:32 mins

Insurance companies are hurting from the high cost of hepatitis C drug Sovaldi. Arthur Caplan, NYU Langone Medical Center, and CNBC's Bertha Coombs, share their opinions.

View Comments (0)